Science-Backed: 8,500 Steps Daily for Sustainable Weight Loss
A new analysis reveals that walking 8,500 steps per day helps sustain weight loss after diet-based programs. Researchers found participants lost nearl...
A new analysis reveals that walking 8,500 steps per day helps sustain weight loss after diet-based programs. Researchers found participants lost nearl...
Hims & Hers Health Inc. (Hims) incurred a $33 million non-cash impairment charge in Q2 2024 due to its strategic pivot toward GLP-1 weight loss medica...
Bariatric surgery rates have dropped since 2022 as GLP-1 medications gain popularity for weight loss. A new Loyola University study reveals shifting t...
A new Rice University study finds that people who lose weight using GLP-1 medications like Ozempic face greater judgment than those who regain weight...
Medicare will launch a pilot program in July 2026 offering GLP-1 weight loss drugs like Wegovy and Zepbound for $50 per month. The initiative, running...
Survodutide, a next-generation GLP-1 drug, achieved a 16.6% reduction in body weight in a Phase 3 trial, outperforming placebo by over 13%. The dual-a...
A groundbreaking AI model developed by researchers at Queen Mary University of London aims to predict 18 serious obesity-related complications by anal...
A new study suggests tirzepatide medications like Mounjaro may lead to greater lean body mass loss compared to semaglutide drugs like Ozempic. Researc...
BioAge Labs announced that its investigational cardiovascular pill, BGE-102, reduced inflammation by 85% in a Phase 1 study of obese patients. The red...
A new study reveals that type 2 diabetes risk among young adults with prediabetes varies widely, with those having high fasting glucose or qualifying...
The FDA has granted fast-track approval to Foundayo, a once-daily GLP-1 pill for weight loss developed by Eli Lilly. The medication, designed for adul...